FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321502213> ?p ?o ?g. }

• W4321502213 endingPage "16" @default.
• W4321502213 startingPage "1" @default.
• W4321502213 abstract "Acute myeloid leukemia (AML) is a heterogeneous malignancy with a low long-term survival rate. The aim of this study was to investigate the effects of decitabine (DAC) treatment cell proliferation and apoptosis in AML and role of the expression of LINC00599 and, consequently, miR-135a-5p.Human promyelocytic leukemia cells (HL-60) and human acute lymphatic leukemia (CCRF-CEM) cells were treated with various concentrations of DAC. Cell proliferation in each group was detected using the cell counting kit 8. For each group, apoptosis and reactive oxygen species (ROS) levels were detected using flow cytometry. Reverse transcription polymerase chain reaction (RT-PCR) was performed to examine the expression of lncRNA LINC00599. The expression of apoptosis-related proteins was analyzed using western blotting. The regulatory relationship between miR-135a-5p and LINC00599 was verified by constructing miR-135a-5p mimics, miR-135a-5p inhibit, wild type LINC00599 3'-untranslated region (UTR), and mutant LINC00599 3'-UTR. Ki-67 expression in the tumor tissues of nude mice was detected using immunofluorescent assays.Both DAC and LINC00599 Inhibit groups were able to significantly reduce the proliferation of HL60 and CCRF-CEM cells, increase apoptosis, upregulate the expression of Bad, cleaved caspase-3, and miR-135a-5p, downregulate the expression of Bcl-2, and elevate ROS levels in cells, with these effects being more pronounced after combined treatment with DAC and LINC00599 Inhibit. In comparison to mimic NC, the miR-135a-5p mimic group significantly decreased the relative fluorescence activity ratio of LINC00599 3'-UTR wild-type CCRF-CEM cells. The LINC00599 Inhibit and miR-135a-5p mimic groups exhibited substantially reduced proliferation of HL60 and CCRF-CEM cells, increased apoptosis, upregulated Bad, cleaved caspase-3, and miR-135a-5p expression, along with downregulated Bcl-2 and LINC00599 expression and increased ROS levels in cells; these effects were more pronounced after LINC00599 Inhibit was combined with miR-135a-5p mimics. In vivo experiments revealed that both DAC and LINC00599 Inhibit were able to considerably reduce the long diameter, short meridian, volume, and mass of tumors, increase miR-135a-5p expression, and decrease LINC00599 and ki-67 expression in tumor tissues of nude mice. This effect was more pronounced when the DAC and LINC00599 Inhibit were used in combination.DAC regulates the expression of miR-135a-5p by regulating the expression of LINC00599, which in turn affects cell proliferation, apoptosis, and tumor proliferation. Our findings provide a theoretical basis for improving the clinical outcome of AML." @default.
• W4321502213 created "2023-02-23" @default.
• W4321502213 creator A5002790683 @default.
• W4321502213 creator A5033908105 @default.
• W4321502213 creator A5056517377 @default.
• W4321502213 date "2023-02-22" @default.
• W4321502213 modified "2023-10-14" @default.
• W4321502213 title "Mechanism of Action of Decitabine in the Treatment of Acute Myeloid Leukemia by Regulating LINC00599" @default.
• W4321502213 cites W1988281870 @default.
• W4321502213 cites W1995354282 @default.
• W4321502213 cites W2013343698 @default.
• W4321502213 cites W2026686516 @default.
• W4321502213 cites W2030489111 @default.
• W4321502213 cites W2040257851 @default.
• W4321502213 cites W2062947546 @default.
• W4321502213 cites W2070777085 @default.
• W4321502213 cites W2308643454 @default.
• W4321502213 cites W2413127596 @default.
• W4321502213 cites W2519786994 @default.
• W4321502213 cites W2594263010 @default.
• W4321502213 cites W2750107048 @default.
• W4321502213 cites W2762563969 @default.
• W4321502213 cites W2769593777 @default.
• W4321502213 cites W2775205444 @default.
• W4321502213 cites W2781538167 @default.
• W4321502213 cites W2784570320 @default.
• W4321502213 cites W2793972506 @default.
• W4321502213 cites W2795382323 @default.
• W4321502213 cites W2922067283 @default.
• W4321502213 cites W2943562845 @default.
• W4321502213 cites W2947379685 @default.
• W4321502213 cites W2984207090 @default.
• W4321502213 cites W2986320711 @default.
• W4321502213 cites W2988052626 @default.
• W4321502213 cites W3014642785 @default.
• W4321502213 cites W3018456970 @default.
• W4321502213 cites W3039848518 @default.
• W4321502213 cites W3045552093 @default.
• W4321502213 cites W3046492307 @default.
• W4321502213 cites W3092915417 @default.
• W4321502213 cites W4313219317 @default.
• W4321502213 doi "https://doi.org/10.1155/2023/2951519" @default.
• W4321502213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36874552" @default.
• W4321502213 hasPublicationYear "2023" @default.
• W4321502213 type Work @default.
• W4321502213 citedByCount "1" @default.
• W4321502213 countsByYear W43215022132023 @default.
• W4321502213 crossrefType "journal-article" @default.
• W4321502213 hasAuthorship W4321502213A5002790683 @default.
• W4321502213 hasAuthorship W4321502213A5033908105 @default.
• W4321502213 hasAuthorship W4321502213A5056517377 @default.
• W4321502213 hasBestOaLocation W43215022131 @default.
• W4321502213 hasConcept C104317684 @default.
• W4321502213 hasConcept C127561419 @default.
• W4321502213 hasConcept C150194340 @default.
• W4321502213 hasConcept C153911025 @default.
• W4321502213 hasConcept C185592680 @default.
• W4321502213 hasConcept C190283241 @default.
• W4321502213 hasConcept C190727270 @default.
• W4321502213 hasConcept C203014093 @default.
• W4321502213 hasConcept C2777527632 @default.
• W4321502213 hasConcept C2778461978 @default.
• W4321502213 hasConcept C2778729363 @default.
• W4321502213 hasConcept C2778903051 @default.
• W4321502213 hasConcept C2779282312 @default.
• W4321502213 hasConcept C2780235182 @default.
• W4321502213 hasConcept C502942594 @default.
• W4321502213 hasConcept C553184892 @default.
• W4321502213 hasConcept C55493867 @default.
• W4321502213 hasConcept C62112901 @default.
• W4321502213 hasConcept C86803240 @default.
• W4321502213 hasConceptScore W4321502213C104317684 @default.
• W4321502213 hasConceptScore W4321502213C127561419 @default.
• W4321502213 hasConceptScore W4321502213C150194340 @default.
• W4321502213 hasConceptScore W4321502213C153911025 @default.
• W4321502213 hasConceptScore W4321502213C185592680 @default.
• W4321502213 hasConceptScore W4321502213C190283241 @default.
• W4321502213 hasConceptScore W4321502213C190727270 @default.
• W4321502213 hasConceptScore W4321502213C203014093 @default.
• W4321502213 hasConceptScore W4321502213C2777527632 @default.
• W4321502213 hasConceptScore W4321502213C2778461978 @default.
• W4321502213 hasConceptScore W4321502213C2778729363 @default.
• W4321502213 hasConceptScore W4321502213C2778903051 @default.
• W4321502213 hasConceptScore W4321502213C2779282312 @default.
• W4321502213 hasConceptScore W4321502213C2780235182 @default.
• W4321502213 hasConceptScore W4321502213C502942594 @default.
• W4321502213 hasConceptScore W4321502213C553184892 @default.
• W4321502213 hasConceptScore W4321502213C55493867 @default.
• W4321502213 hasConceptScore W4321502213C62112901 @default.
• W4321502213 hasConceptScore W4321502213C86803240 @default.
• W4321502213 hasFunder F4320322186 @default.
• W4321502213 hasLocation W43215022131 @default.
• W4321502213 hasLocation W43215022132 @default.
• W4321502213 hasLocation W43215022133 @default.
• W4321502213 hasOpenAccess W4321502213 @default.
• W4321502213 hasPrimaryLocation W43215022131 @default.
• W4321502213 hasRelatedWork W1756125747 @default.
• W4321502213 hasRelatedWork W2100640927 @default.

• next